Front Immunol March 2024 PMID 38433830

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants.

Maria Iacobescu, Cristina Pop, Alina Uifălean, Cristina Mogoşan, Diana Cenariu, Mihnea Zdrenghea, Alina Tănase, Jon Thor Bergthorsson, Victor Greiff, Mihai Cenariu, Cristina Adela Iuga, Ciprian Tomuleasa, Dan Tătaru

Download social card

Mentions

5
Peak: 3 in Feb 2024
across 2 sources since Feb 2024

Extended reach

41,814
potential audience

Total likes

118

Video views

6,410

Mentions per month

Feb 2024 – Mar 2025

Where it's discussed

  • X / Twitter3 posts
  • YouTube2 videos

AI synopsis

What people are saying

The discussions emphasize the importance of identifying biomarkers for GVHD and reference the publication as a promising step forward, using words like 'potential' and 'advancement.' The tone demonstrates enthusiasm for the prospects of non-invasive diagnostics and the future impact on patient care, reflecting support and interest in the research's implications.

AgreementModerate agreement

Most discussions acknowledge the importance and potential of proteomics for GVHD diagnosis, reflecting general support for the research focus.

InterestHigh interest

The discussions show high engagement with positive reactions, often highlighting the significance of the findings and their potential impact.

EngagementModerate engagement

Participants delve into commentary on the methods and implications, suggesting a moderate to high level of engagement and curiosity.

ImpactModerate impact

Posts imply that this research could influence future diagnostic strategies, indicating a perceived moderate impact on clinical practices.

Abstract in brief

  • Allogeneic hematopoietic stem cell transplants (allo-HSCT) come with significant benefits but also carry risks like graft-versus-host disease (GVHD) during preconditioning and after the procedure.*
  • Effective risk management and early detection of GVHD rely on clinical features, highlighting the need for tools that can identify and manage patients proactively.*
  • This review focuses on the promise of proteomics-based biomarkers from non-invasive samples to improve diagnosis and treatment strategies for acute and chronic GVHD in patients undergoing allo-HSCT.*

Top posts

Most liked on X and Bluesky
Frontiers - Immunology
@FrontImmunol · X

New Research: Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants: Despite the numerous advantages of allogeneic hematopoietic stem cell transplants (allo-HSCT),… https://t.co/juRSE075LE #immunology

Feb 16, 2024 · 6 likes · 2 shares · 33,756 followers View post →
Shams Salah Mahdi
@ShamsPath · X

RT @FrontImmunol: New Research: Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic…

Feb 16, 2024 · 2 shares · 1,437 followers View post →

All mentions

Elisabetta Massone
@EMassone2 · X

RT @FrontImmunol: New Research: Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic…

Feb 16, 2024 · 2 shares · 200 followers View post →
Shams Salah Mahdi
@ShamsPath · X

RT @FrontImmunol: New Research: Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic…

Feb 16, 2024 · 2 shares · 1,437 followers View post →
Frontiers - Immunology
@FrontImmunol · X

New Research: Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants: Despite the numerous advantages of allogeneic hematopoietic stem cell transplants (allo-HSCT),… https://t.co/juRSE075LE #immunology

Feb 16, 2024 · 6 likes · 2 shares · 33,756 followers View post →